Alpha 2.0
Login Register
» Articles » PMID: 5451357

Effects of Iron, Riboflavin and Iodide Deficiencies on Hepatic Drug-metabolizing Enzyme Systems

Overview
Journal J Pharmacol Exp Ther
Specialty Pharmacology
Date 1970 Aug 1
PMID 5451357
Citations 5
Authors
C S Catz
M R Juchau
S J Yaffe
Affiliations
Soon will be listed here.
Citing Articles

Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.

Feere D, Velenosi T, Urquhart B Br J Pharmacol. 2014; 172(1):201-13.

PMID: 25219905 PMC: 4280978. DOI: 10.1111/bph.12932.

Hepatic drug hydroxylation and lipid peroxidation in riboflavin-deficient rats.

Patel J, Galdhar N, Pawar S Biochem J. 1974; 140(3):363-8.

PMID: 4374935 PMC: 1168012. DOI: 10.1042/bj1400363.

Metabolism of sulphadiazine in malnutrition.

Arunkumar Shastri R, Krishnaswamy K Br J Clin Pharmacol. 1979; 7(1):69-73.

PMID: 760744 PMC: 1429609. DOI: 10.1111/j.1365-2125.1979.tb00899.x.

Drug metabolism and pharmacokinetics in malutrition.

Krishnaswamy K Clin Pharmacokinet. 1978; 3(3):216-40.

PMID: 350472 DOI: 10.2165/00003088-197803030-00003.

Hepatic heme metabolism and its control.

Bonkowsky H, Sinclair P, Sinclair J Yale J Biol Med. 1979; 52(1):13-37.

PMID: 222077 PMC: 2595705.